751 related articles for article (PubMed ID: 11129646)
21. The cellular basis of immune induction at mucosal surfaces by DNA vaccination.
Barnfield C; Brew R; Tilling R; Rae A; Wheeler C; Klavinskis LS
Dev Biol (Basel); 2000; 104():159-64. PubMed ID: 11713815
[TBL] [Abstract][Full Text] [Related]
22. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
[TBL] [Abstract][Full Text] [Related]
23. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
24. New understanding of immunological mechanisms.
Saalmüller A
Vet Microbiol; 2006 Oct; 117(1):32-8. PubMed ID: 16701965
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
[TBL] [Abstract][Full Text] [Related]
26. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines.
Wang C; Ge Q; Ting D; Nguyen D; Shen HR; Chen J; Eisen HN; Heller J; Langer R; Putnam D
Nat Mater; 2004 Mar; 3(3):190-6. PubMed ID: 14991022
[TBL] [Abstract][Full Text] [Related]
27. Fully mobilizing host defense: building better vaccines.
Raychaudhuri S; Rock KL
Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
[TBL] [Abstract][Full Text] [Related]
28. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.
Heath WR; Belz GT; Behrens GM; Smith CM; Forehan SP; Parish IA; Davey GM; Wilson NS; Carbone FR; Villadangos JA
Immunol Rev; 2004 Jun; 199():9-26. PubMed ID: 15233723
[TBL] [Abstract][Full Text] [Related]
29. DNA vaccines: successes and limitations in cancer and infectious disease.
Lowe DB; Shearer MH; Kennedy RC
J Cell Biochem; 2006 May; 98(2):235-42. PubMed ID: 16440328
[TBL] [Abstract][Full Text] [Related]
30. DNA vaccines against HPV-16 E7-expressing tumour cells.
De Marco F; Hallez S; Brulet JM; Gesché F; Marzano P; Flamini S; Marcante ML; Venuti A
Anticancer Res; 2003; 23(2B):1449-54. PubMed ID: 12820408
[TBL] [Abstract][Full Text] [Related]
31. The immunology of cutaneous DNA immunization.
Tüting T
Curr Opin Mol Ther; 1999 Apr; 1(2):216-25. PubMed ID: 11715945
[TBL] [Abstract][Full Text] [Related]
32. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity.
Stubbs AC; Martin KS; Coeshott C; Skaates SV; Kuritzkes DR; Bellgrau D; Franzusoff A; Duke RC; Wilson CC
Nat Med; 2001 May; 7(5):625-9. PubMed ID: 11329066
[TBL] [Abstract][Full Text] [Related]
33. Expression library immunization to discover and improve vaccine antigens.
Barry MA; Howell DP; Andersson HA; Chen JL; Singh RA
Immunol Rev; 2004 Jun; 199():68-83. PubMed ID: 15233727
[TBL] [Abstract][Full Text] [Related]
34. CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes.
Stan AC; Casares S; Brumeanu TD; Klinman DM; Bona CA
Eur J Immunol; 2001 Jan; 31(1):301-10. PubMed ID: 11265647
[TBL] [Abstract][Full Text] [Related]
35. [Naked DNA vaccines].
Spitz M
Medicina (B Aires); 2000; 60(5 Pt 1):639-44. PubMed ID: 11188908
[TBL] [Abstract][Full Text] [Related]
36. DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
Stevenson FK; Rice J; Ottensmeier CH; Thirdborough SM; Zhu D
Immunol Rev; 2004 Jun; 199():156-80. PubMed ID: 15233733
[TBL] [Abstract][Full Text] [Related]
37. Genetic immunization with GPI-anchored anthrax protective antigen raises combined CD1d- and MHC II-restricted antibody responses by natural killer T cell-mediated help.
Midha S; Bhatnagar R
Vaccine; 2009 Mar; 27(11):1700-9. PubMed ID: 19195490
[TBL] [Abstract][Full Text] [Related]
38. Soluble cytokines can act as effective adjuvants in plasmid DNA vaccines targeting self tumor antigens.
Disis ML; Shiota FM; McNeel DG; Knutson KL
Immunobiology; 2003; 207(3):179-86. PubMed ID: 12777059
[TBL] [Abstract][Full Text] [Related]
39. Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms.
Payette PJ; Weeratna RD; McCluskie MJ; Davis HL
Gene Ther; 2001 Sep; 8(18):1395-400. PubMed ID: 11571579
[TBL] [Abstract][Full Text] [Related]
40. Potential advantages of DNA immunization for influenza epidemic and pandemic planning.
Webster RG
Clin Infect Dis; 1999 Feb; 28(2):225-9. PubMed ID: 10064231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
